Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion type Assertion NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_head.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion wasGeneratedBy ECO_0000203 NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion wasDerivedFrom befree-2016 NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion SIO_000772 22587422 NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion evidence source_evidence_literature NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.